<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01071525</url>
  </required_header>
  <id_info>
    <org_study_id>Niacin-OS</org_study_id>
    <nct_id>NCT01071525</nct_id>
  </id_info>
  <brief_title>The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Treatment of Hypercholesterolemic patients with niacin will cause a significant decrease
           in oxidative stress and a decrease in the atherogenecity in blood samples of the
           patients.

        2. A possible correlation between oxidative stress in hypercholesterolemic patients taking
           niacin to clinical hypercholesterolemia parameters is possible.

        3. Using a novel biomarker will enable a precise detection of the change in the oxidative
           stress in hypercholesterolemic patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect on oxidative stress</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Niacin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hypercholesterolemic patients with high-density lipoprotein (HDL) less than 40 mg% will receive Niacin\Laropiprant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Maching subjects will receive no medication, Blood tests will be drawn for laboratory tests.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Niacin\Laropiprant</intervention_name>
    <description>Hypercholesterolemic patients with low HDL will receive Niacin\Laropiprant</description>
    <arm_group_label>Niacin</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypercholesterolemia,

          -  age above eighteen

        Exclusion Criteria:

          -  Treatment with fibrates,

          -  Pregnant/Breast feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liz Phima</last_name>
    <role>Study Director</role>
    <affiliation>Study Coordinator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shadi Hamoud, Dr</last_name>
    <phone>+972-523591876</phone>
    <email>s_hamoud@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shadi</last_name>
      <phone>+972-523591876</phone>
      <email>s_hamoud@rambam.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Tony Hayek, Prof</last_name>
      <phone>+972-523782009</phone>
      <email>t_hayek@rambam.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Tony Hayek, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2010</study_first_submitted>
  <study_first_submitted_qc>February 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2010</study_first_posted>
  <last_update_submitted>February 25, 2010</last_update_submitted>
  <last_update_submitted_qc>February 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Shadi Hamoud</name_title>
    <organization>Rambam Health Care Campus</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Niacinamide</mesh_term>
    <mesh_term>Nicotinic Acids</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 6, 2015</submitted>
    <returned>May 21, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

